Please ensure Javascript is enabled for purposes of website accessibility

The Big Election Win for Marijuana Hardly Anyone Is Talking About

By Keith Speights – Nov 13, 2018 at 6:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This state didn't vote to legalize recreational marijuana, but it did the next best thing.

Marijuana turned out to be one of the biggest winners on election day in the U.S. last week. Michigan residents voted to legalize recreational marijuana. Missouri and Utah voters passed ballot initiatives that legalized medical marijuana. Democrats regained control of the U.S. House of Representatives, which should increase the prospects for federal marijuana reform.

However, there's another major election victory for marijuana that few are talking about. Billionaire businessman J.B. Pritzker won the Illinois gubernatorial race. And it could lead to more good news for the U.S. cannabis industry.

Now entering Illinois sign with a marijuana leaf drawn on it

Image source: Getty Images.

Land of Lincoln, land of weed?

Pritzker handily defeated Illinois' incumbent Republican governor Bruce Rauner. And he did so on a definitively pro-marijuana platform. 

A month before the election, Pritzker stated that, if elected, he planned to "put in place a framework to license businesses to sell marijuana to consumers for recreational use." With his victory now in hand, he intends to get the ball rolling on the legalization of recreational marijuana soon after he's sworn in as the next governor of Illinois in early 2019. 

Illinois already allows the legal sale and use of medical marijuana. However, the state imposed strict regulations that made it challenging for businesses to get up and running successfully. Legislation signed by Rauner earlier this year will allow patients who are prescribed opioids to use medical marijuana, a move that will expand the state's medical cannabis market.

Arcview Market Research and BDS Analytics estimate that medical marijuana sales in Illinois will total nearly $150 million this year. By 2022, that figure is projected to increase to $400 million. However, these estimates don't factor in the possibility that Illinois could legalize recreational marijuana. 

Illinois' population is nearly one-third the size of California, which is projected to generate $7.7 billion in legal marijuana sales by 2022. It's possible that Illinois could eventually claim a legal marijuana market of around $2.5 billion, or more, if Pritzker delivers on his pledge to legalize recreational marijuana.

Potential winners

Another multibillion-dollar cannabis market would certainly make some businesses big winners. Several marijuana stocks appear to be top candidates for that group.

Chicago-based Green Thumb Industries (GTBIF -4.33%) could be in great shape to profit from the opening of a legal recreational marijuana market in Illinois. Green Thumb Industries (GTI) currently focuses only on marijuana markets in eight states, including Illinois. The company's operations span the supply chain from cultivation, to manufacturing, to wholesale and retail. GTI was one of three marijuana stocks that billionaire investor Leon Cooperman disclosed last month that he had personally bought. 

MedMen Enterprises (MMNFF -2.19%) is another potential winner if Illinois legalizes recreational marijuana. The company ranks as the largest U.S. cannabis retailer. MedMen announced in October that it plans to acquire PharmaCann, one of the largest medical cannabis producers and dispensary operators in the U.S., and it's headquartered in Oak Park, Illinois. The PharmaCann deal will give MedMen a presence in 12 states, including Illinois.

MariMed (MRMD -0.46%) should also have a nice opportunity in Illinois with the potential legalization of recreational marijuana. The company focuses on helping marijuana growers by designing and developing production facilities, and by providing professional management services.

Although MariMed isn't based in Illinois, the company built and leases a cannabis production facility in the state. It also acquired Betty's Eddies last year. Betty's Eddies is the most popular brand of cannabis edibles in Illinois.

A few hurdles

There are still several hurdles to jump before the election of J.B. Pritzker truly turns into a victory for marijuana stocks. Pritzker must first be sworn in. He then must successfully advance legislation to legalize recreational marijuana. 

There are two things working in his favor. First, Illinois doesn't require a constitutional amendment to legalize recreational marijuana. All it takes is for the bill to pass the state's Senate and House of Representatives. Also, Democrats enjoy supermajorities in both legislative chambers. That will make it much easier for Pritzker to advance his agenda.

Assuming such legislation is passed in 2019, it will still probably take between 12 and 18 months before recreational marijuana is available legally in Illinois. Still, the odds of that happening are pretty good now. The Illinois gubernatorial results could end up handing the marijuana industry one of its biggest wins of the 2018 U.S. elections.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

MariMed Inc. Stock Quote
MariMed Inc.
MRMD
$0.44 (-0.46%) $0.00
MedMen Enterprises Stock Quote
MedMen Enterprises
MMNFF
$0.04 (-2.19%) $0.00
Green Thumb Industries Stock Quote
Green Thumb Industries
GTBIF
$9.27 (-4.33%) $0.42

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
107%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.